Cingulate ticker
WebDec 7, 2024 · Cingulate Inc. (“Cingulate” or the “Company”), today announced the pricing of its initial public offering of 4,166,666 shares of common stock and accompanying warrants to purchase 4,166,666 shares of common stock. ... The shares and warrants are scheduled to begin trading on the Nasdaq Capital Market under the ticker symbols “CING ... WebDec 10, 2024 · The shares and warrants began trading on the Nasdaq Capital Market under the ticker symbols “CING” and “CINGW,” respectively, on December 8, 2024. ...
Cingulate ticker
Did you know?
WebDec 8, 2024 · The shares and warrants are scheduled to begin trading on the Nasdaq Capital Market under the ticker symbols “CING” and “CINGW,” respectively, on … WebApr 10, 2024 · Company Description. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of …
WebApr 11, 2024 · A high-level overview of Cingulate Inc. (CING) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebApr 8, 2024 · Open an account. Provide your personal information and sign up. Fund your account. Deposit funds unto your account by linking your banking information or transfer …
WebApr 10, 2024 · Get Cingulate Inc (CING:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebDec 14, 2024 · Issuer Name and Ticker or Trading Symbol Cingulate Inc. [ CING] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: Officer (give title below) ...
WebSep 10, 2024 · Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention deficit hyperactivity disorder ...
WebOct 4, 2024 · IPO details. Cingulate Inc. is slated to go public on Thursday, October 7. The company will begin trading on NASDAQ under the ticker symbol CING. It will offer 4.6 million shares at a price range of $10 to $12 to raise $50.1 million. The IPO will be managed by a group of underwriters led by Oppenheimer & Co. howdens wishaw opening timesWebJan 25, 2024 · Cingulate Inc. (NASDAQ: CING), is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a ... how many rotational symmetry of a rhombusWebAnalyze quarterly positions in Cingulate with up to 7 years of data, all consolidated into one spreadsheet Download as csv Download as Excel Top investors of Cingulate stock how many rotations does earth make in one dayWebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug … how many roth accounts can one person haveWebMar 10, 2024 · Debt. Other. Inside Cingulate Inc.'s 10-K Annual Report: Financial - Expense Highlight. We have experienced, and will continue to experience, increased expenses associated with being a public company, including costs of accounting, audit, legal, regulatory and tax compliance services; director and officer insurance; and investor and … how many roth conversion allowed per yearWebJul 13, 2024 · Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity … how many ross storesWebSep 16, 2024 · It plans to trade under the ticker CING. Timed release. What makes Cingulate’s product different than those offered by competitors is that its product slowly releases medication throughout the day whereas other medicines take effect almost immediately and cause a “crash” later, according to the company’s prospectus. howdens witney opening hours